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abstract 
Background: Candidiasis is an opportunistic infection commonly occurs on host with immunodeficiency, organ transplantation, 
leukopenia, or radiation therapy. Biofilms are structures that protect C. albicans from antifungals treatments. C. albicans biofilms 
display multidrug resistance to antifungal agents. Purpose: This study aimed to know whether the combination of Cinnamomum 
burmannii, Vigna unguiculata, and Papain extracts derived from Carica papaya latex has inadequate inhibitory effects against 
C.albicans biofilms compared to the combination of Cinnamomum burmannii and Vigna unguiculata extracts. Method: C. albicans 
growing on SDA were dissolved in 1 McFarland of sterile aquadest. Micro-plate was filled with 180 µL of SDB, glucose 8%, and 20 
µL of C. albicans. Suspension was incubated at 37oC overnight. Extracts were added and incubated for 24 hours. Then, each well was 
washed with distilled water, and stained with crystal violet 0.1% for 15 minutes. Afterward, each well was washed with distilled water 
and immediately stained with acetic acid. After 15 minutes of staining, the suspension was transferred to a new well, then measured 
with micro-plate reader at 595 nm. Results: The combination of Cinnamomum burmanii and Vigna unguiculata extracts had adequate 
inhibitory effects  which is equal to 60.75%. Inhibition increased to 72.09%, 79.06%, and 79.50% after Papain derived from Carica 
papaya latex was added on concentrations of 138 mg/mL, 276 mg/mL, and 552 mg/mL. Conclusion: The combination of Cinnamomum 
burmanii (0.25µg/mL), Vigna unguiculata (200 µg/mL), and Papain (276 µg/mL) extracts showed an optimum synergic inhibition for 
C. albicans biofilms. 
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introduction
Opportunistic fungal infection has been discussed in 
this decade. The ability of fungi to be able to infect the host 
actually depends on the immune response of the host and 
the presence of xenobiotics. Opportunistic fungal infections 
are mostly caused by Candida species infections.1 
Candida albicans (C. albicans) grows excessively 
in patients with low immune circumstances, such as 
human immunodeficiency virus (HIV) infection, organ 
transplantation, leukopenia, post-surgery, or radiation 
therapy. Thrush or oropharyngeal candidiasis is a fungal 
infection found on the surface of the oral mucosa, therefore, 
the ability of C. albicans to form biofilms has a huge impact 
on its ability to cause disease.2
Results of a research on patients with HIV / AIDS 
showed that the prevalence of oral candidiasis from 2008 to 
2009 in Cipto Mangunkusumo Hospital was approximately 
80.8%, while in Dr. Hasan Sadikin Hospital about 27% 
and in H. Adam Malik Hospital about 28.7%. Similarly, 
McCullough said that 70-80% of oral candidiasis is caused 
by C. albicans.3
Laboratory diagnosis and treatment of diseases caused 
by Candida species, especially C. albicans, Furthermore, 
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has not given satisfactory results because of the resistance 
to common antifungal. C. albicans biofilms have more 
multidrug resistance to fluconazole, amphotericin B, 
flucytosine, itraconazole, and ketoconazole than C. albicans 
in free-cells.1
Biofilms, moreover, are structured microbial 
communities, which are bound to the surface and become 
embedded in an extracellular matrix polymer produced.4 
Extracellular matrix provides a significant contribution 
to drug resistance in C. albicans biofilms. Extracellular 
matrix is composed of materials considered as causative 
factors of resistance. Biofilms cannot be penetrated by 
antifungal for C. albicans cells coated by β-glucans, chitin, 
and glycoproteins. The realization of this biofilm is a self-
defense form of C. albicans against radical agents.4 
In addition, Cinnamon (Cinnamomum burmannii) is 
known to have antimicrobial properties. Cinnamomum 
burmannii contains with sinamaldehid, eugenol, cinnamic 
acid, sesquiterpene, and proanthocyanidin, which have 
antimicrobial power. Extract of Cinnamomum burmannii 
has a minimum inhibitory concentration (MIC) of 0.33 mg/
mL against C. albicans.5
Papain derived from Carica papaya latex and 
fluconazole, furthermore, has synergistic action in inhibiting 
the growth of C. albicans. The result is a synergistic effect 
to degrade the cell wall of C. albicans. Papain is responsible 
as antifungal at a concentration of 138 μg/mL. Papain 
containing a specific content in the form of Nasetil-β-D-
glukosaminidase and α-D-mannosidase is known to have a 
role in the degradation of C. albicans biofilm matrix .6
Tolo bean extract (Vigna unguiculata), moreover, 
is known to contain the β-1,3-glucanase enzyme. Vigna 
unguiculata at a concentration of 200 μg/mL has higher 
activity of β-1,3-glucanase enzyme that at a concentration 
of 3.152 U/mg.8 The combination of β-1,3-glucanase 
enzymes derived from snails and Cinnamomum burmannii 
extract is able to lyse C. albicans biofilm, and the result is 
the death of C. albicans biofilm cells, about 75%.5
Snails have β-1,3-glucanase enzymes, but the enzymes 
are unstable. It is reported that β-1,3-glucanase enzymes 
derived from snails and stored at room temperature has 
glucanase activity decreasing dramatically. Similarly, in the 
storage temperature of 24oC, the activity of β-1,3-glucanase 
also decreases.6 Enzymes from Vigna unguiculata have 
good stability and high glucanase activity.7
In short, Cinnamomum burmannii extract will degrade 
free albicans cells. 8 Extracellular matrix of C. albicans 
biofilms is composed of β-glucan (50-60%), mannoprotein 
(30-40%), and chitin (0.6 to 9%).4 β 1,3-glucanase enzyme 
derived from Vigna unguiculata extract is able to hydrolyze 
the components of the extracellular matrix in the glucanase 
form.7 α-β-D-mannosidase derived from Papain is able 
to hydrolyze the components of the biofilm matrix in the 
form of mannoprotein, while N-acetyl-β Dglukosaminidase 
of Papain is able to hydrolyze components of the biofilm 
matrix in the form of chitin.6 In other words, the use of 
Cinnamomum burmannii extracts has antimicrobial activity, 
while the combination of Vigna unguiculata and Papain 
extracts derived from Carica papaya latex is synergistic 
in the extracellular matrix of the biofilms hydrolyzing 
C. albicans. This aim of this study was to know whether 
the combination of Cinnamomum burmannii, Vigna 
unguiculata, and Papain extracts derived from Carica 
papaya latex has inadequate inhibitory effects against 
C. albicans biofilms compared to the combination of 
Cinnamomum burmannii and Vigna unguiculata extracts.
materials and methods 
This research is an experimental laboratory research 
with post-test-only control group design. The research 
was conducted at Rumah Sakit Khusus Infeksi (Hospital 
for Infection) Universitas Airlangga in October-November 
2015. Samples used in this research were albicans. 
The number of samples used were determined by using 
Lemeshow formula, about seven samples.
The samples were divided into five groups. The control 
group consisted of C. albicans planktonics and C. albicans 
biofilms without being treated. Group I consisted of C. 
albicans planktonics and C. albicans biofilms treated with 
0.25 mg/mL of Cinnamomum burmannii extract and 200 
μg/mL of Vigna unguiculata extract. Group II consisted of 
C. albicans planktonics and C. albicans biofilms treated 
with 0.25 mg/mL Cinnamomum burmannii extract, 200 μg/
mL of Vigna unguiculata extract, and 138 μg/mL of papain 
extract. Group III consisted of C. albicans planktonics and 
C. albicans biofilms treated with 0.25 mg/mL Cinnamomum 
burmannii extract, 200 μg/mL of Vigna unguiculata extract, 
and 276 μg/mL of papain extract. Group IV consisted of 
C. albicans planktonics and C. albicans biofilms treated 
with 0.25 mg/mL Cinnamomum burmannii extract, 200 
μg/mL of Vigna unguiculata extract, and 552 μg/mL of 
Papain extract.
This research was started with the preparation of 
Cinnamomum burmannii, Vigna unguiculata, and Papain 
extracts. The extracts of Cinnamomum burmannii and 
Vigna unguiculata were obtained from Balai Penelitian 
dan Konsultasi Industri (Research and Industry Consulting 
Center) in Surabaya together with aquadest as solvent. 
Meanwhile, papain extract was derived from Carica 
papaya latex obtained from SIGMA (P3X15-250). Next, 
25 mg of Cinnamomum burmannii extract was dissolved 
in 100 mL of distilled water. Vigna unguiculata extract 
then was added in a concentration of 200 mg/mL, whereas 
Papain extract was added in concentrations of 138 mg/mL, 
276 mg/mL, and 552 mg/mL. 
C. albicans planktonics and biofilms were prepared by 
using microtiterdish assay method. C. albicans taken from 
SDA stock was used to make suspension in 1 McFarland of 
sterile distilled water (3 x 107 CFU/mL). Microplates then 
were filled with 180 mL of SDB together with 8% glucose 
and 20 mL of C. albicans to grow C. albicans biofilm. 
Meanwhile, to grow C. albicans planktonics, Micro-plates 
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then were filled with 180 mL of SDB together and 20 mL 
of C. albicans without 8% glucose.
Afterwards, those micro-plates were incubated for 24 
hours at 37°C. They then were washed with sterile aquadest 
before the extracts were added into them and incubated for 
24 hours. After that, the micro-plates were washed again, 
and then stained with 0.1% crystal violet for 15 minutes. 
Those micro-plates were washed with sterile distilled water. 
They then were given with acetic acid for 15 minutes and 
transferred to a new ones. OD values  were read using micro 
plate reader at a wavelength of 595 nm.10,11 Inhibition 
effect then was determined based on the values of OD. If 
OD values  obtained were getting smaller, inhibition effect 
would be indicated to be high. The formula used to calculate 
the inhibitory activity was as follows:11
(Mean of OD595 Control – mean of OD595 
Concentration)
× 100%
Mean of OD595 Control
The normality of data were tested using Kolmogorov 
Smirnov test, while the homogeneity of data were tested 
using Levenne’s Test. Finally, to identify the significance 
of the difference among the treatment groups, Post Hoc-
Tukey HSD test was conducted.12
results
Absorbance levels of planktonic and biofilm cells 
were observed in the value of optical density (OD) using a 
microplate reader with a wavelength of 595 nm. OD value 
obtained then was comparable with C. albicans biofilm 
formation. To determine the growth of C. albicans biofilms, 
a preliminary experiment on the relation of C. albicans 
biofilm growth and incubation time was conducted, and 
the results showed that the optimal biofilm growth was at 
24 hours.
After knowing the optimal incubation time for C. 
albicans biofilm to grow well, a combination of the extracts 
was used to inhibit the growth of C. albicans biofilms. This 
aimed to compare the effectiveness of the combination of 
Cinnamomum burmannii, Vigna unguiculata, and papain 
extracts in inhibiting the growth of C. albicans biofilms. 
In the control group, C. albicans planktonic cells was 
untreated with C. albicans biofilm. In this research, the 
concentration of Cinnamomum burmannii extract used 
was 0.25 mg/mL, the concentration of Vigna unguiculata 
extract was also the same or equal to 200 pg/ml, while 
the concentrations of papain extract were 138 μg/ml, 
276 pg/ml, and 552 μg/ml. The results of OD values 
obtained were as follows (Table 1).  
Based on Table 1 above, it can be seen that the means 
of OD values of C. albicans planktonics was 0.367, while 
the means of OD values of C. albicans biofilm was 0.688. 
The OD value of C. albicans biofilms was higher than 
the OD values of C. albicans planktonics. The OD value 
of C. albicans biofilms dropped to 0.27 after treated with 
the combination of Cinnamomum burmannii and Vigna 
unguiculata extracts. The OD value of C. albicans biofilms 
decreased into 0.192 after treated with the combination 
of the Cinnamomum burmannii, Vigna unguiculata, 138 
μg/mL of papain extracts. The OD value of C. albicans 
biofilms  remained down to 0.144 after Papain concentration 
was increased to 276 mg/mL, and the OD value declined 
into 0.141 after the addition of papain concentration to 552 
mg/mL. The comparison of the OD values of C. albicans 
planktonics and C. albicans biofilms in the control group 
and the OD values of C. albicans biofilms treated can be 
seen in the graph below (Figure 1).
Table 1. The OD values of C. albicans biofilms after the 
treatment 
Treatment groups N 
Means of SD
OD values
Planktonic cells 7 0.367 0.530
Biofilms 7 0.688 0.174
CB +VU extracts 7 0.270 0.187
CB +VU + P138 extracts 7 0.192 0.304
CB +VU + P276 extracts 7 0.144 0.207
CB +VU + P552 extracts 7 0.141 0.149
Note: CB: Cinnamomum burmanii extract; VU: Vigna 
unguiculata extract; P138: 138 μg/mL of Papain; P276: 276 μg/
mL of papain; P552: 552 μg/mL of Papain.
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Figure 1. The graph of OD Values of C. albicans biofilms with 
various treatment.
Table 2. The inhibition percentage of C. albicans biofilms
Treatment groups N 
The inhibition 
percentage 
CB +VU extracts 7 60.75 % 
CB +VU +P138 extracts 7 72.09 % 
CB +VU +P276 extracts 7 79.06 % 
CB +VU +P552 extracts 7 79.50 % 
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The inhibition percentage of C. albicans biofilms 
obtained can be seen in Table 2. The inhibition percentage 
of the combination of Cinnamomum burmannii and Vigna 
unguiculata extracts against C. albicans biofilms in the 
control group was 60.75%. The inhibition percentage 
of the combination of Cinnamomum burmannii, Vigna 
unguiculata, and 138 ug/mL of Papain extracts was 
72.09%. The inhibition percentage of the combination 
of Cinnamomum burmannii, Vigna unguiculata, and 276 
mg/mL of Papain extracts was 79.06%. Meanwhile, the 
inhibition percentage of the combination of Cinnamomum 
burmannii, Vigna unguiculata, and 552 μg/mL of Papain 
extracts was 79.50%.
A statistical test was conducted on distribution of data in 
each group using the Kolmogorov-Smirnov test. The results 
of Kolmogorov-Smirnov test showed that the distribution of 
data in those treatment groups was normal because p-value 
in the treatment groups was greater than 0.05. After that, 
Levenne test was conducted to know the homogeneity 
of data. The results of Levenne test showed that p-value 
obtained was <0.05. It means that the variation of the data 
was not homogeneous. As a result, Kruskal Wallis test 
was performed. The results of Kruskal Wallis test showed 
that value obtained was > 0.05. It indicates that there were 
significant differences between each treatment group.
To know the differences of each treatment group, Post 
Hoc-Tukey HSD test then was carried out. The results 
of Post Hoc-Tukey HSD test showed that there was a 
significant difference between the group treated with 
biofilms and the treatment groups treated with CB + VU 
extracts, CB + VU + P138 extracts, CB + VU + P276, 
and CB + VU + P552 extracts. Similarly, there was also a 
significant difference between the group treated with CB + 
VU extracts and the groups treated with CB + VU + P276 
and CB + VU + P552 extracts.
discussion
In the process of biofilm inhibition, there are some 
stages of the degradation of the elements of C. albicans 
biofilm biomass. Extracellular matrix is  one of the elements 
composing the biomass of biofilms. One of the elements 
composing the extracellular matrix of the biofilms is 
glucan (50.60%). The hydrolysis mechanism of glucanase 
contained in Vigna unguiculata against C. albicans biofilm 
is related to glucan in the cell walls of fungi that can be 
utilized by glucanase enzyme as a substrate by cutting 
the glucose residues of non-reducing end of polymers or 
oligomers, resulting in forming a glucose monomer.13
Cinnamomum burmannii has several compounds that 
play a role in degradation of C. albicans cells, such as 
sinamaldehide and eugenol. The ability of sinamaldehide 
in inhibiting the growth of C. albicans due to the free 
3-phenyl group that can bind to aspartic proteases in the 
wall of C. albicans cells and also bind to oxygen required 
for the metabolism of C. albicans. These bounds can cause 
sinamaldehide inhibits the synthesis of enzymes on the wall 
of C. albicans cells and the metabolism of C. albicans cells, 
resulting in the death of C. albicans cells.8
Eugenol, is known to be lipophylic, which can penetrate 
between fatty acid chains and layers of bilayer membrane by 
altering the permeability of cell membranes. If the phenol 
compound interacts with the cell wall of C. albicans, there 
will be denaturation of proteins in the cells of C. albicans. 
The interaction causes a change in the balance of protein 
molecules, resulting in a change in the structure of the 
protein and triggering coagulation. Protein experiencing 
coagulation will lose its physiological activities that cannot 
function properly. Changes in the structure of proteins in 
C. albicans will cause increased permeability of the cells, 
so the cell growth is inhibited and then the cells will die, 
thus eugenol has an ability to reduce adherent and to inhibit 
metabolism of C. albicans biofilms. 14 
Therefore, in the treatment group, the inhibition was 
adequate when C. albicans biofilms were treated with 
combination of Cinnamomum burmannii and Vigna 
unguiculata compared to the control group. It means that 
the combination of Cinnamomum burmannii and Vigna 
unguiculata extracts is able to inhibit C. albicans biofilms 
with the inhibition of 60.75%.
In addition, papain contains specific enzymes, namely 
αD-mannosidase and N-acetyl-β-Dglucosaminidase 
hydrolyzing the extracellular matrix of the biofilms, such 
as mannoprotein and chitin. Glycosidase process of both the 
enzymes of Papain can occur by cutting the polysaccharide 
chain residues in the extracellular matrix of biofilms.6
In the other treatment group, moreover, the inhibition 
was adequate when 276 mg/mL of Papain was added to 
the combination of Cinnamomum burmannii and Vigna 
unguiculata used to treat C. albicans biofilms. Papain 
extract at that concentration could inhibit C. albicans 
biofilms with good inhibitory, increasing from 60.75% to 
79.06%. It means that there was an increase in the inhibition 
of 18.31%.
The addition of papain extract at the concentrations 
ranging from 138 mg/mL to 276 pg/mL and 552 mg/mL did 
not show adequate inhibition. papain can be active when 
given activator since the enzyme contained in papain can be 
activated or inhibited. Compounds classified as activators of 
papain are cysteine, sufida and sulfite, as well as a chelator 
of heavy metals, such as EDTA and N-bromosuksinimida; 
whereas compounds classified as inhibitors of papain are 
PMSF, TLCK & TPCK, E-64, heavy metals, cystatin, and 
leupeptin.15 However, papain used in this research was not 
classified as an activator. Thus, OD values  of the inhibition 
of  C. albicans biofilms obtained were inadequate though 
the concentration of papain increased.
Another possibility is C. albicans can develop some 
mechanisms to overcome the existing antimicrobial agents 
by producing genetic mutation enzyme and transmission for 
new generation.16 In the process of extract administration, 
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the incubator temperature was 37°C. This possibility 
also becomes a factor causing the working of Papain on 
C. albicans biofilms not optimal. Concentration level 
(pH), furthermore, is also considered as a factor that can 
influence the effectiveness of the activity of the enzyme. 
The effectiveness of the enzyme showed a gradual increase 
with increasing pH from pH 3.5 to pH 7.5, whereas at 
pH 9 resulting in a decrease in the activity of papain.17 
Meanwhile, in the treatment groups, PBS pH used as a 
solvent was 7. It can be concluded that the combination 
of 0.25 mg/mL of Cinnamomum burmannii, 200 mg/mL 
of Vigna unguiculata, and 276 mg/mL of papain extracts 
had an optimal and synergistic effect on the inhibition of 
C. albicans biofilms.
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